{"product_id":"10th-annual-diabetes-obesity","title":"10th Annual Diabetes, Obesity, \u0026 Metabolic Disease Conference 2025 Videos+Slides","description":"\u003ch2\u003e10th Annual Diabetes, Obesity, \u0026amp; Metabolic Disease Conference 2025 Videos+Slides\u003c\/h2\u003e\n\u003ch2\u003eGeneral Information\u003c\/h2\u003e\u003cbr\u003eContinuing Education Company provides primary care clinicians continuing medical education (CME) designed to improve patient outcomes by enhancing your knowledge, competence, and performance through evidence-based in-person conferences\u003cbr\u003e\u003cbr\u003eRelease date April 2025\u003cbr\u003e\u003cbr\u003eruntime around 20 HOurs\u003cbr\u003e\u003ch3\u003eOverview\u003c\/h3\u003e\u003cbr\u003eThis CME activity is comprised of recordings from the \u003cstrong\u003e10th Annual Diabetes, Obesity, and Metabolic Disease Conference\u003c\/strong\u003e that took place at the Westin San Diego Gaslamp Quarter in San Diego, California on April 25-27, 2025. This CME is designed to update primary care clinicians in rapidly changing therapeutic areas. The emphasis is on practical and useful information for clinical practice. The CME conference will educate and promote improved patient outcomes in a broad range of therapeutic areas commonly encountered in the primary care practice.\u003cbr\u003e\u003cbr\u003eCardiometabolic disorders are a cluster of health conditions associated with cardiovascular disease and type 2 diabetes. It is estimated that over 1\/3 of Americans suffer from a cardiometabolic disorder. The associated morbidity and mortality deserve increased clinical attention as we address risk factors predisposing individuals to these disorders. This program will help identify these conditions and their related complications to enable clinicians to appropriately intervene with evidence-based treatments and risk-factor control while improving patient education.\u003cbr\u003e\u003cbr\u003eThis course features sessions designed to update primary care clinicians involved in the treatment of patients at risk of cardiometabolic disorders. Topics include: Treating Obesity to Treat Diabetes, The Cardiovascular-Kidney-Metabolic Syndrome, 2025 ADA Standards of Care, Identifying and Treating HFpEF, Cases in Diabetes, Renal and Cardio-Kidney Metabolic Disease, The Biology of Obesity, Harnessing Anti-Obesity Medications, Midlife Metamorphosis in Women, Strategies for Optimizing Outcomes of Obesity Treatment, Cases in Obesity Management, Diagnosis and Management of MASLD\/MASH, Secondary Causes of Hypertension, Treatment of LDL-C\/Non-HDL-C\/Apo B-Statins, Triglycerides and Lp(a), and Cases in Hypertension and Dyslipidemia.\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eKey Features\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eEngaging content from renowned experts\u003c\/li\u003e\n\u003cli\u003ePersonalized learning experience – learn at your own pace, on your own schedule, and in your preferred environment\u003c\/li\u003e\n\u003cli\u003e16 HD-quality video-based lectures and presentation handouts\u003c\/li\u003e\n\u003cli\u003eCME365™ – Accessible anywhere, anytime – stream online for viewing at your leisure\u003c\/li\u003e\n\u003cli\u003e15.25 CME\/CE credits for physicians, nurses, and PAs, and ABIM MOC\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003eCourse Content\u003c\/h3\u003e\n\u003ctable cellpadding=\"0\" cellspacing=\"0\" class=\"course-content-table\"\u003e\n\u003ccolgroup\u003e\n\u003ccol\u003e\n\u003ccol\u003e\n\u003c\/colgroup\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003eOn Demand Replay: FRIDAY, April 25, 2025\u003cbr\u003eDAY 1 – Diabetes and Cardio-Renal Disease Management with Cases\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM. McDonnell, MD\u003c\/td\u003e\n\u003ctd\u003eTreating Obesity to Treat Diabetes: Cutting the Gordian Knot\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eN. Desai, MD\u003c\/td\u003e\n\u003ctd\u003eThe Cardiovascular-Kidney-Metabolic Syndrome: Timely Identification, Optimal Management, and Lingering Questions\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM. McDonnell, MD\u003c\/td\u003e\n\u003ctd\u003eHighlights from the 2025 ADA Standards of Care: Drug Selection, Technology and Nutrition\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eN. Desai, MD\u003c\/td\u003e\n\u003ctd\u003eIdentifying and Treating HFpEF: It’s All About the Phenotype…\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM. McDonnell, MD \u0026amp; N. Desai, MD\u003c\/td\u003e\n\u003ctd\u003eCases in Diabetes, Renal and Cardio-Kidney Metabolic Disease\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\u003cbr\u003e \u003cbr\u003e\u003ctable cellpadding=\"0\" cellspacing=\"0\" class=\"course-content-table\"\u003e\n\u003ccolgroup\u003e\n\u003ccol\u003e\n\u003ccol\u003e\n\u003c\/colgroup\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003eOn Demand Replay: SATURDAY, April 26, 2025\u003cbr\u003eDAY 2 – Comprehensive Obesity Management and MASLD\/MASH with Case Studies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eL. Kaplan, MD\u003c\/td\u003e\n\u003ctd\u003eThe Biology of Obesity and its Implications for Effective Treatment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD. Thiara, MD\u003c\/td\u003e\n\u003ctd\u003eBeyond the Scale: Harnessing Anti-Obesity Medications to Treat Obesity and its Complications\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eD. Thiara, MD\u003c\/td\u003e\n\u003ctd\u003eMidlife Metamorphosis in Women: Tackling Obesity During Aging and Menopause\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eL. Kaplan, MD\u003c\/td\u003e\n\u003ctd\u003eStrategies for Optimizing Outcomes of Obesity Treatment\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eL. Kaplan, MD \u0026amp; D. Thiara, MD\u003c\/td\u003e\n\u003ctd\u003eCases in Obesity Management\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM. Rinella, MD\u003c\/td\u003e\n\u003ctd\u003eDiagnosis and Management of MASLD\/MASH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eM. Rinella, MD\u003c\/td\u003e\n\u003ctd\u003eCases in the Diagnosis and Management of MASLD\/MASH\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\u003cbr\u003e \u003cbr\u003e\u003ctable cellpadding=\"0\" cellspacing=\"0\" class=\"course-content-table\"\u003e\n\u003ccolgroup\u003e\n\u003ccol\u003e\n\u003ccol\u003e\n\u003c\/colgroup\u003e\n\u003cbr\u003e\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd colspan=\"2\"\u003eOn Demand Replay: SUNDAY, April 27, 2025\u003cbr\u003eDAY 3 – Hypertension and Dyslipidemia Management with Case Studies\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJ. Basile, MD (Chairperson)\u003c\/td\u003e\n\u003ctd\u003eUpdate on Secondary Causes of Hypertension\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eC. Ballantyne, MD\u003c\/td\u003e\n\u003ctd\u003eTreatment of LDL-C, Non-HDL-C and Apo B-Statins and Beyond\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eC. Ballantyne, MD\u003c\/td\u003e\n\u003ctd\u003eTriglycerides and Lp(a): Where Are We Now and Where Are We Going?\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eJ. Basile, MD \u0026amp; C. Ballantyne, MD\u003c\/td\u003e\n\u003ctd\u003eCases in Hypertension and Dyslipidemia\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003cbr\u003e\n\u003c\/table\u003e\n\u003chr\u003e\n\u003ch3\u003eCourse Objectives\u003c\/h3\u003e\u003cbr\u003eAs a result of this educational activity, participants should be better able to:\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eDiagnose and identify cardiometabolic risk factors, including diabetes, dyslipidemia, hypertension, and obesity.\u003c\/li\u003e\n\u003cli\u003eIntegrate evidence-based strategies and recent guidelines for the screening, prevention, and treatment of cardiometabolic risk factors and their comorbidities in clinical practice.\u003c\/li\u003e\n\u003cli\u003eIncorporate appropriate interventions, including lifestyle modifications, nutrition counseling, and drug and surgical therapies, based on a specific patient’s risk profile.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003chr\u003e\n\u003ch3\u003eTarget Audience\u003c\/h3\u003e\u003cbr\u003eThis activity is designed for physicians, nurse practitioners, physician assistants, and other healthcare professionals specializing in primary care and family medicine.","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954508435554,"sku":"MED-AMB04964","price":85.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/10th-Annual-Diabetes-Obesity-Metabolic-Disease-Conference-2025-VideosSlides.png?v=1779378480","url":"https:\/\/meducourse.com\/products\/10th-annual-diabetes-obesity","provider":"Meducourse","version":"1.0","type":"link"}